Building precision psychiatry.

Reduce subjective bias while preserving clinical judgment. Structured frameworks plus emerging objective measures replace freeform recall with auditable signal.

• Symptom identification mapped directly to DSM criteria with full audit trail
• Structured assessment on validated, peer-reviewed clinical frameworks
• Patent-pending vocal biomarkers for psychosis, depression and anxiety
• Multi-modal fusion of interviews, sessions, PROMs and biomarkers

Mental health is a trajectory. Mira captures the full arc — between visits, across episodes, over years — so clinicians see change as it happens.

• Automated check-ins between visits with symptom tracking
• PROM cadence delivered by phone or kiosk, scored over time
• Episode progression capture — PRIME study on first-episode psychosis relapse
• Treatment-response curves visible the next time a patient walks in

Standardised assessment delivered by voice agent and kiosk multiplies clinician capacity and brings rigorous psychiatry to populations who can't access it today.

• Voice agent conducting structured DAs over the phone, on demand
• Walk-in kiosk for triage, intake, PROMs and UDS — no scheduling required
• Patent-pending voice biomarkers enabling scalable, objective measurement
• Consistent quality across diverse populations and care settings

The same data that makes assessment objective also makes treatment specific. Mira moves toward prediction — matching the right intervention to the right patient at the right time.

• Real-time SmartTips surfacing relevant findings during the encounter
• Treatment-response prediction for TMS and esketamine (in research)
• Publication in Translational Psychiatry on prediction models
• Care plans informed by the patient's own longitudinal signal

Edwin is co-founder and CEO of Psyrin, where he leads the company's strategy and partnerships. He completed his PhD at King's College London and the National University of Singapore, working on large-scale genetic studies for psychiatry. Before Psyrin, Edwin was active in deeptech innovation via Entrepreneur First and Nucleate UK.

Julianna leads Psyrin's technological and scientific innovation, with a focus on real-world clinical impact. She earned her PhD from King's College London for pioneering work on the use of voice biomarkers to identify mental illness. She founded Hungary's largest digital therapy marketplace, which has supported 10,000+ mental health sessions.

Raheem leads clinical implementations and operational change, bringing clinician perspectives into our work and partnerships. He completed his medical degree at King's College London and worked as a resident doctor in liaison psychiatry at King's College Hospital before leaving clinical practice to co-found Psyrin.

Omar drives the development of voice- and language-based models that power our clinical products. He first worked with Psyrin while completing his Master's in Artificial Intelligence at University College London. Before that, he developed AI tools for mental health, including a platform using sentiment analysis to flag suicide risk.

Jordan brings biomedical science expertise and technology leadership to Psyrin's mission. With experience scaling operations at Tesla and founding a venture-backed startup, Jordan combines scientific understanding with proven ability to implement complex technology solutions in regulated environments.

Cesar builds scalable, secure, and dependable platforms. He has led products from concept to production, emphasizing reliability and thoughtful system design. With experience in mental health technology, he brings a product-driven mindset and a commitment to secure, user-centered solutions.

Board-certified psychiatrist and co-founder of Radial and The Frontier Psychiatrists. A practitioner at the forefront of technology-driven psychiatric care, with hands-on experience building and scaling AI-assisted clinical workflows in behavioral health settings.

Psychiatrist and researcher at Northwell Health specialising in psychosis, social cognition, and automated speech and language markers for tracking psychiatric symptoms — work that directly informs Psyrin's voice biomarker and longitudinal assessment platform.

CMO at UnitedHealth Group and former VP & CMO of Carelon Behavioral Health at Elevance Health, overseeing behavioral health integration across more than 100 million covered lives. Deep expertise in payer-side clinical strategy, population health, and large-scale behavioral health deployment.